Clinical Trials
3
Active:0
Completed:0
Trial Phases
1 Phases
Phase 2:3
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials
Phase 2
3 (100.0%)Role of Hypersensitivity to Female Sex Hormones in Women With Unexplained Recurrent Pregnancy Loss
Phase 2
- Conditions
- Abortion, Recurrent
- Interventions
- Drug: Skin test panel
- First Posted Date
- 2010-08-05
- Last Posted Date
- 2010-08-05
- Lead Sponsor
- EVE Medical Systems Ltd.
- Target Recruit Count
- 40
- Registration Number
- NCT01175759
- Locations
- 🇭🇺
Depts. Gynecology and Obstetrics and 3rd Dept of Internal Medicine, Budapest, Hungary
Evaluation of Safety/Efficacy of Diagnostic Skin Test Panel and Desensitization Hormone Kit for Treatment of Premenstrual Syndrome (PMS)
Phase 2
- Conditions
- Premenstrual Syndrome
- Interventions
- Drug: Skin test panel and desensitization kitDrug: Skin test panel and solvent
- First Posted Date
- 2009-04-01
- Last Posted Date
- 2010-06-16
- Lead Sponsor
- EVE Medical Systems Ltd.
- Target Recruit Count
- 20
- Registration Number
- NCT00873262
- Locations
- 🇮🇱
Tel Aviv Sourasky Medical Center, Tel Aviv, Israel
Evaluation of Efficacy/Safety of EVE-PMS Skin Test Panel
Phase 2
- Conditions
- Premenstrual Syndrome
- Interventions
- Drug: Skin test panel
- First Posted Date
- 2009-03-20
- Last Posted Date
- 2010-06-16
- Lead Sponsor
- EVE Medical Systems Ltd.
- Target Recruit Count
- 40
- Registration Number
- NCT00866437
- Locations
- 🇮🇱
Sheba Medical Center, Tel-Hashomer, Ramat Efal, Israel
News
No news found